Sarepta Therapeutics, Inc.
Extract: Bylaws Amendment (Plain English Desc) from a 8-K on 01/13/2020   Download
SEC Document
SEC Filing

On January 8, 2020, the Board amended Article III, Section 3.02 of the Amended and Restated Bylaws of the Company to increase the maximum number of directors that can serve on the Board from seven (7) to eight (8), effective January 8, 2020 (the “Amendment”).